Madison Today

By the People, for the People

Stock Markets

Recent news

Cinctive Capital Management Invests in Exact Sciences

Hedge fund takes stake in medical research company known for its Cologuard cancer screening test.

Boothbay Fund Management Buys Stake in Alliant Energy

The investment firm acquired over 34,000 shares of the utility company in the third quarter.

Ameriprise Financial Boosts Stake in Exact Sciences

Investment firm increases holdings in medical research company by over 100%

Exact Sciences Hits New 1-Year High

Shares of the medical research company reach a new 52-week high.

Granahan Investment Management Trims Exact Sciences Holdings

Institutional investor reduces stake in medical research company by 12.6% in Q3

Bridgefront Capital Buys Shares in Exact Sciences

Institutional investor adds 11,994 shares of medical research company to portfolio

Aquatic Capital Management Boosts Stake in Exact Sciences

The investment firm increased its position in the medical research company by 213.6% during the third quarter.

Bamco Inc. NY Boosts Stake in Exact Sciences Corporation

The investment firm increased its position in the medical research company by nearly 15% in the third quarter.

Exact Sciences Corporation $EXAS is Spyglass Capital Management LLC's 2nd Largest Position

Spyglass Capital Management LLC increased its stake in the medical research company by 56.4% in the third quarter.

Swiss National Bank Sells 37,000 Shares of Alliant Energy Corporation

Institutional investor reduces stake in utility company

Korea Investment CORP Reduces Stake in Alliant Energy Corporation

The firm sold over 50,000 shares of the utility company in the third quarter.

Alliant Energy Shares Sold by Natixis Advisors

Investment firm trims stake in energy company by 5.8% in third quarter

Analysts Set Exact Sciences Corporation (NASDAQ:EXAS) Target Price at $92.13

The average 12-month price target among analysts covering the stock is $92.13.

Schroder Investment Management Boosts Stake in Exact Sciences

Investment firm increases holdings in medical research company by nearly 50%

Capital World Investors Reduces Stake in Exact Sciences

Institutional investor cuts position in medical research company by 11.3% in Q3

Blair William & Co. IL Reduces Stake in Exact Sciences Corporation

Investment firm cuts position in medical research company by 14.9% in Q3

Exact Sciences Reaches New 52-Week High

Analysts Weigh In on Whether the Stock Is Still a Buy

Wall Street Zen Upgrades MGE Energy Stock

Analysts raise rating on utility company from "sell" to "hold"

Wall Street Zen Downgrades MGE Energy to 'Sell'

Other analysts have also issued mixed ratings on the utility company's stock.

Wall Street Zen Downgrades Alliant Energy to Sell

Analysts cut rating from "hold" to "sell" on the utility company's stock.